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Edited by Jesus AvilaAbstract Calcium-binding equine lysozyme (EL) combines the
structural and folding properties of c-type lysozymes and a-lact-
albumins, connecting these two most studied subfamilies. The
structural insight into its native and partially folded states is par-
ticularly illuminating in revealing the general principles of pro-
tein folding, amyloid formation and its inhibition. Among
lysozymes EL forms one of the most stable molten globules
and shows the most uncooperative refolding kinetics. Its par-
tially-folded states serve as precursors for calcium-dependent
self-assembly into ring-shaped and linear amyloids. The innate
amyloid cytotoxicity of the ubiquitous lysozyme highlights the
universality of this phenomenon and necessitates stringent mea-
sures for its prevention.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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EL occupies a special position within the extended family of
structurally homologous proteins – lysozymes and a-lactalbu-
mins. These are among the most studied objects providing a
wealth of information on the mechanisms of structural organi-
zation, folding and amyloidogenicity of polypeptides. EL is
viewed as an evolutionary link between them, as it possesses
the structural and folding features of both subfamilies [1,2]. Spe-
ciﬁcally, it contains the active-site residues Glu 35 and Asp 52,
involved in lysozyme enzymatic (EL) activity [3,4], and the con-
served, high-aﬃnity calcium-binding site of a-lactalbumins [5]
(Fig. 1). Consequently, EL acts as a bacteriolytic enzyme similar
to lysozymes, ubiquitous components in the many body ﬂuids
and tissues of all mammalians, while a-lactalbumins take part
in lactose biosynthesis in the mammary glands [5]. Due to
EL’s extremely low stability and cooperativity compared to
non-calcium-binding c-type lysozymes, it forms equilibrium
partially folded states similar to a-lactalbumins [6–8]. However,
like c-type lysozymes it populates well-deﬁned transient kinetic
intermediates [9], which enables us to compare the equilib-
rium and kinetic species of the same protein. EL can also self-Abbreviations: EL, equine lysozyme
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doi:10.1016/j.febslet.2007.05.023assemble into amyloids with a very distinctive ring-shaped
and linear morphology [10,11]. They diﬀer from the ﬁbrils of
both lysozymes involved in systemic amyloidoses [12,13] and
a-lactalbumins, forming amyloids in vitro [14]. Here we review
the EL folding, misfolding and amyloid properties in view of
their general implications for understanding the underlying
mechanisms and causes of these processes.2. Calcium-binding property
Lysozymes/a-lactalbumins consist of two sub-domains
(Fig. 1): the a-domain is rich in a-helical structure, while the
b-domain contains a triple-stranded b-sheet and several loops.
They possess also a conserved pattern of four disulﬁdes. The
EL calcium-binding property was initially predicted [15], since
in the domain interface it has the same calcium-binding ligands
as a-lactalbumins (Fig. 1). Then the binding constant of
2 · 106 M1 was determined experimentally [1] and the struc-
ture of the binding-site conﬁrmed by crystallographic and
NMR structural analysis [2–4]. The presence of the calcium-
binding site most likely contributes to EL’s signiﬁcantly lower
stability and cooperativity compared to c-type lysozymes [6–9].
If hen and human lysozymes undergo highly cooperative two-
state thermal denaturation above 70 C, and even the amyloi-
dogenic variants of human lysozyme are destabilized by only
ca. 12 C [16,17], then, by contrast, apo-EL displays a three-
state transition in a wide range between room temperature
and 80 C (Fig. 2a) [18,19]. The ﬁrst denaturation transition
is calcium-dependent and leads to molten globule formation;
upon calcium-binding it is shifted to signiﬁcantly higher tem-
peratures. EL’s unfolding behaviour, however, cannot be de-
scribed by two-state model even at very high calcium
content. Similarly, the three-state unfolding of EL was ob-
served upon chemical denaturation [7]. The thermodynamic
behaviour of EL within the ﬁrst thermal unfolding transition
was described by a four-state scheme [18], where N and I cor-
respond to apo-native and apo-intermediate states, and NM
and IM – to holo-forms, respectively.
ð1Þblished by Elsevier B.V. All rights reserved.
Fig. 2. (a) Speciﬁc heat capacity of EL at various calcium concentra-
tions [18]. Concentration of calcium was controlled by adding 1 mM
EDTA (red), 1 mM CaCl2 (blue), 10 mM CaCl2 (black) or no additives
in control measurements (green). (b) Phase-diagrams of EL (solid
lines) and bovine a-lactalbumin (dashed curve); EL states are denoted
as in Eq. (1).
Fig. 1. Schematic diagram of EL demonstrating the folding areas with
local cooperatively [9]. They are colour-coded as follows: violet,
corresponding to the rapidly folded A, B and D a-helical core, blue –
the 59–61 residue b-strand stabilized with 50–100 ms time constants,
green-the C-helix, 120–150 ms time constants, yellow – the elements of
secondary structures attaining persistent structure with 200–250 ms
time constants, orange – the middle 51–55 residue b-strand, ca. 400 ms
time constants, and red, denoting the most slowly stabilized loops. The
disulphide bridges are shown in ball-and-stick.
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‘‘phase-diagram’’ was build, visualizing the population of EL
conformations in the coordinates of free-calcium concentra-
tion and temperature. The ‘‘phase diagrams’’ of EL and a-lact-
albumin both share a similarity (Fig. 2b) [18,20], indicating
that stabilization of the structure around the calcium-binding
site and domain interface is critical for both proteins.3. EL structural characterization
The EL crystal structure has been determined at a 2.5 A˚ res-
olution, demonstrating a structural homology with lysozymes
and a calcium-binding loop similarity to a-lactalbumins [4].
The 1H NMR spectrum of holo-EL shows the high degree of
resonance dispersion characteristic of lysozymes [3,21]. Back-
bone chemical shifts as well as sequential and long-range
NOEs closely resemble those of human and hen lysozymes,
providing evidence of the similarity between their solution
structures. As in crystallographic studies the major chemical
shift deviations were observed for the residues located in the
calcium-binding loop [3,21]. The calcium-binding site was ana-
lyzed by 113Cd and 43Ca NMR, conﬁrming its match with
those of bovine and human a-lactalbumins [22,23].The amide hydrogen exchange protection measurements of
holo-EL, probing both the structure and dynamic of molecule,
show a pattern similar to those of human and hen lysozymes,
i.e. the protection of amides in all major secondary structure
elements [21]. However, the protection factors are on average
600-fold lower than in human and hen lysozymes. This corre-
lates well with the EL’s lower stability [6–8,18] and with the
thermodynamic calculations of the protein equilibrium folding
pathways [24].4. The origin of molten globule stability
The molten globules of a-lactalbumins were the earliest dis-
covered and most studied partially folded states [25,26]. Classic
molten globules are compact states with native-like secondary
structures, but with a few tertiary contacts compared to native
proteins. Understanding the diﬀerences between the molten
globule and native states is critical for clarifying the mecha-
nisms of protein folding and stability. Most lysozymes do
not readily form equilibrium molten globules, but EL is a
notable exception, as it enters into various molten globule
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8,18,21]. They display some features of a-lactalbumin molten
globules, being compact and possessing conformational mobil-
ity in the millisecond time scale. However, they are signiﬁ-
cantly more stable, exhibiting cooperative unfolding
transitions and the pronounced circular dichroism signals both
in the near and far-UV regions, indicative of the presence of
persistent tertiary interactions [6–8,18,21].
Amide proton exchange analysis provided residue-speciﬁc
information on the nature of EL molten globule stability
[8,21]. The acidic A-state of EL showed high protection of
the A, B and D a-helices and particularly the amides of hydro-
phobic residues located at the helical interface, making con-
tacts with other residues of the core (Fig. 1). A model of the
molten globule was proposed, which possesses an extended
hydrophobic core based on the native-like tertiary interactions
of the three out of four major a-helices. This was the most sta-
ble molten globule within the lysozyme-a-lactalbumin family
[8,21]. Recently, a molten globule with a similar core, but more
stabilized a-helices, was observed in canine calcium-binding
lysozyme [27,28]. Thus, if the ﬁrst thermodynamic transition
of EL corresponds to the conversion of the native state to
the molten globule, then the unfolding of the core, rather than
the whole a-domain [19], gives an enthalpic contribution to the
second transition to the thermally-unfolded state [7,8,27,28].
The particular role of the D helix in maintaining the native-like
core was demonstrated by designing the chimeras of human
and bovine a-lactalbumins, carrying the D helix of EL and dis-
playing the stability of EL molten globule [29,30]. Using poly-
peptide constructs of diﬀerent length, Chowdhury et al. [31]
showed that more extensive interactions than those in a-do-
main are required to generate a stable molten globule in two
calcium-binding equine and canine lysozymes. The structural
characterization of the EL molten globule clearly demonstrates
that the native-like packing can signiﬁcantly contribute to non-
speciﬁc rudimentary hydrophobic interactions initially persis-
tent in the intermediate states.5. Ensemble of kinetic intermediates
The kinetics of EL native state formation is described as an
extremely uncooperative process, occurring via the heteroge-
neous assembly of the numerous regions characterized by inde-
pendent nucleation and local cooperativity (Fig. 1) [9]. The
kinetic events were monitored by using several techniques such
as amide hydrogen exchange pulse-labelling coupled with
NMR and stopped-ﬂow circular dichroism, intrinsic and dye
ﬂuorescence spectroscopy, providing an insight into the stabil-
ization of the secondary and tertiary structures and the burial
of hydrophobic surfaces [9,32]. The folding reactions attrib-
uted to diﬀerent molecular regions were characterized by time
constants from a few to hundreds milliseconds. A burst-phase
folding intermediate was formed in the whole population of
molecules within the dead time of experiments [9]. It possesses
the persistent A, B and D a-helical core, closely resembling the
core observed in the EL equilibrium molten globule (Fig. 1)
[8,21]. The most protected B helix is central to both equilib-
rium and kinetic intermediates. Mizuguchi et al. [32] also dem-
onstrated the similarity between the EL burst-phase
intermediate and equilibrium molten globule. Both results
emphasize that the former is an obligatory intermediate onthe folding pathway and the latter is an important structural
model of short-lived kinetic species [8,9,32,33].
The overall assembly into the native state proceeded in a dif-
ferent order within the given population of EL molecules,
implying the involvement of multiple folding pathways. In
some molecules the further step, occurring on a timescale of
hundred milliseconds, involved the stabilization of the remain-
ing C helix in the a-domain. In others the persistent structure
began to develop in the b-domain, involving three kinetically
distinguishable steps, with the middle b-strand stabilized last
of all (Fig. 1). Residues in the loop regions throughout the pro-
tein attained persistent structures most slowly. Based on these
observations, the model of the most uncooperative EL folding
compared to other c-type lysozymes was proposed [9,34,35],
which provided an experimental basis for the theoretical simu-
lation of multiple folding pathways in a free energy folding
landscape [36]. It is interesting to note, that in a-lactalbumins
the transient species with some persistent structure in the a-do-
main were also detected. However, the weak protection against
solvent exchange, measured for bovine a-lactalbumin, suggests
that the ensemble of molecules formed early in the folding
reaction contains not much common and persistent structure,
which is preserved through the folding process [37]. There is no
evidence of the existence of well-deﬁned discrete folding inter-
mediates of the type populated during refolding of EL, human
and hen lysozymes [9,34,35]. The folding of members of lyso-
zyme-a-lactalbumins super-family emphasizes that the native
state in structurally homologous proteins can be attained via
very diverse folding pathways. The common feature for all
members of this super-family is that the nucleation site is lo-
cated in the a-domain, but the structural elements involved
in the initial core as well as the order and rate of assembly
of subsequent structural regions are highly sequence speciﬁc.6. Partially folded states as amyloid precursors
The interest in both equilibrium and kinetic intermediates
was stimulated recently due to their implication as precursor-
states in aggregation and amyloid formation [38,39]. It was
suggested that the amyloidogenicity of human lysozyme vari-
ants involved in systemic amyloidosis originates from their
lower global stability and cooperativity compared to the
wild-type protein and the decrease in the stability of the na-
tive-fold relative to partially-folded intermediates [40–42]. In-
deed, both wild-type lysozyme and Asp57Ile/His67Thr
variants form amyloid ﬁbrils in vitro, if their partially folded
states are populated [12]. Therefore, the stabilization of lyso-
zyme was suggested as a valuable pharmaceutical approach
[43]. EL as a naturally destabilized lysozyme also assembles
into amyloid protoﬁlaments under the conditions of its molten
globule formation at acidic pH [10]. However, compared to
human lysozyme ﬁbrils, which undergo maturation, lengthen-
ing and thickening [12], the EL protoﬁlaments remain single-
stranded and never exceed a few hundred nanometers
(Fig. 3b and c) [10]. This fact may be attributed to the presence
of the very stable core in its structure, persistent even under
amyloid forming conditions [10]. Although the polypeptide se-
quences most likely forming the ﬁbrillar cross-b-sheet are
encompassed in the b-domain [10,44], the stable a-helical core
provides a non-adhesive ﬁbrillar interface, preventing signiﬁ-
cant ﬁbrillar growth. These results suggest that it is not only
Fig. 3. Relating EL amyloid morphology and cytotoxicity [10,11]. (a)
Atomic force microscopy images of cytotoxic amyloid oligomers
produced at pH 4.5, calcium content was not controlled; (b) non-toxic
EL protoﬁlaments; (c) an individual protoﬁlament and its cross-
section; (d–f) EL amyloid-rings constituted of oligomers; (g) the
decrease of viability of primary neuronal cell culture in the presence of
EL samples, containing the amyloid tetramers, octamers and eikosi-
mers (20) (black bars) and the tetramers and octamers (striped bars),
respectively.
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amyloid formation, but also the conformational plasticity of
the polypeptide chains involved in the ﬁbrillar interface. There-
fore, the design of the regions with a high local stability andcooperativity, in addition to the overall stabilization of protein
molecules, can be broadly explored as an amyloid-preventing
strategy in the applications involving proteinaceous com-
pounds [45].
It is important to note that the amyloid precursor states of
both EL and human lysozyme share one common feature –
the formation of polyproline-type II helix [46,47]. In both pro-
teins the C-helix, located at the domain interface, is a potential
candidate for this conformation. This helix is characterized by
a signiﬁcant conformational plasticity and a propensity to con-
vert into b-sheet. Polyproline-type II helix was observed in the
amyloid precursor states of other proteins and can be consid-
ered as a signature of this state or a ‘‘killer conformation’’
[46,47].7. Calcium-regulated amyloid formation
The morphology of EL amyloids depends strongly on
solution conditions, including calcium concentration, pH and
temperature [10]. The holo-EL assembles into linear protoﬁla-
ments, while the apo-protein forms ring-shaped amyloids
(Fig. 3b–f). All amyloid samples are polymorphic as shown
in Fig. 3a and b, consisting of a mixture of various size oligo-
mers and protoﬁlaments. The amyloid-rings are varied in
diameters, which equal to 45–50 nm at pH 4.5 and 70–80 nm
at pH 2.0, respectively [10]. They bind amyloid dyes Congo
red and thioﬂavin T similar to the disease related amyloid-
rings of Ab peptide and a-synuclein. Amyloid-ring formation
was suggested as a major pathogenic cause in Alzheimer’s
and Parkinson’s diseases [48]. The observation of EL amy-
loid-rings highlights that they are not limited to disease-related
polypeptides, but represent a second generic type of amyloids
in addition to more common linear ﬁlaments [10].8. Innate amyloid cytotoxicity
Cytotoxicity is one of the major properties gained by pro-
teins as a result of their self-assembly into amyloids. Already
EL amyloid tetramers and even more markedly octamers
and eikosimers (20), determined by atomic force microscopic
analysis, exhibit this innate cytotoxic activity on various cell
types (Fig. 3a and g) [11]. This property has a transient nature
and diminishes as soon as protoﬁlaments are formed. It has
been suggested that the amyloid cross-b-sheet core develop-
ment is critical for the oligomeric toxicity, stabilizing them
from dissociation upon penetration through cellular mem-
branes and within the cellular environment [49]. Soluble amy-
loid oligomers may assemble into rings. However, there was no
correlation between the population of the amyloid-rings and
the cytotoxicity of the samples with an equal protein con-
centration, demonstrating that the size and the structural
properties of the constituting oligomers rather than the ring-
formation determine the amyloid toxicity [11].
It is interesting to note that the amyloids of hen lysozyme,
formed under similar conditions of acidic pH as EL’s ones,
also exhibit cytotoxicity [50]. The amyloid oligomers initiate
apoptosis-like pathways, while the ﬁbrils induce necrosis-like
cell death. This suggests that the type of cytotoxicity may de-
pend on amyloid morphology or/and the primary structure
L.A. Morozova-Roche / FEBS Letters 581 (2007) 2587–2592 2591of precursor-protein, but that is not limited to a particular
amyloid species, being an inherent property of a wide range
of amyloids.9. Concluding remarks
EL proved to be a rich and invaluable resource for protein
researchers. In-depth studies of EL have enriched our under-
standing of the general folding mechanisms, revealing the link
between equilibrium and kinetic intermediates, the origin of
their stability and their pivotal role in amyloid assembly.
The observation of an ensemble of kinetic intermediates
and multiple folding pathways provided an experimental dem-
onstration of the complexity of the theoretically simulated
energy folding landscape. The calcium-regulated amyloid
self-assembly and innate amyloid toxicity of such an abundant
protein as lysozyme emphasizes the universality of this phe-
nomenon. Undesired protein aggregation and amyloid assem-
bly, arising from protein instability, is a common event,
occurring spontaneously in vivo and in vitro and being poten-
tially highly hazardous. Therefore, they demand careful assess-
ments, particularly in the growing areas of industrial
applications of polypeptide-based products, such as biophar-
maceuticals [45]. Analyzing the folding and amyloid properties
of EL we suggest that amyloid propagation can be eﬀectively
limited or prevented by a targeted design within the protein
molecule of the relevant local areas with a high stability and
cooperativity. This strategy can be explored in biopharmaceu-
tical applications, in order to ensure more highly functional
and safe products [45].
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